Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Transdermal Skin Patch Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Transdermal Skin Patch Market Status and Forecast (2016-2027)
      • 1.3.2 Global Transdermal Skin Patch Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Transdermal Skin Patch Supply by Company

    • 2.1 Global Transdermal Skin Patch Sales Volume by Company
    • 2.2 Global Transdermal Skin Patch Sales Value by Company
    • 2.3 Global Transdermal Skin Patch Price by Company
    • 2.4 Transdermal Skin Patch Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Transdermal Skin Patch Market Status by Category

    • 3.1 Transdermal Skin Patch Category Introduction
      • 3.1.1 Fentanyl Transdermal Skin Patch
      • 3.1.2 Nicotine Transdermal Skin Patch
      • 3.1.3 Clonidine Transdermal Skin Patch
      • 3.1.4 Buprenorphine Transdermal Skin Patch
    • 3.2 Global Transdermal Skin Patch Market by Category
      • 3.2.1 Global Transdermal Skin Patch Sales Volume by Category (2016-2021)
      • 3.2.2 Global Transdermal Skin Patch Sales Value by Category (2016-2021)
      • 3.2.3 Global Transdermal Skin Patch Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Transdermal Skin Patch Market Status by End User/Segment

    • 4.1 Transdermal Skin Patch Segment by End User/Segment
      • 4.1.1 Relieve Severe Pain
      • 4.1.2 Stop Smoking Cigarettes
      • 4.1.3 Treat an Overactive Bladder
      • 4.1.4 Others
    • 4.2 Global Transdermal Skin Patch Market by End User/Segment
      • 4.2.1 Global Transdermal Skin Patch Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Transdermal Skin Patch Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Transdermal Skin Patch Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Transdermal Skin Patch Market Status by Region

    • 5.1 Global Transdermal Skin Patch Market by Region
      • 5.1.1 Global Transdermal Skin Patch Sales Volume by Region
      • 5.1.2 Global Transdermal Skin Patch Sales Value by Region
    • 5.2 North America Transdermal Skin Patch Market Status
    • 5.3 Europe Transdermal Skin Patch Market Status
    • 5.4 Asia Pacific Transdermal Skin Patch Market Status
    • 5.5 Central & South America Transdermal Skin Patch Market Status
    • 5.6 Middle East & Africa Transdermal Skin Patch Market Status

    6 North America Transdermal Skin Patch Market Status

    • 6.1 North America Transdermal Skin Patch Market by Country
      • 6.1.1 North America Transdermal Skin Patch Sales Volume by Country (2016-2021)
      • 6.1.2 North America Transdermal Skin Patch Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Transdermal Skin Patch Market Status

    • 7.1 Europe Transdermal Skin Patch Market by Country
      • 7.1.1 Europe Transdermal Skin Patch Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Transdermal Skin Patch Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Transdermal Skin Patch Market Status

    • 8.1 Asia Pacific Transdermal Skin Patch Market by Country
      • 8.1.1 Asia Pacific Transdermal Skin Patch Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Transdermal Skin Patch Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Transdermal Skin Patch Market Status

    • 9.1 Central & South America Transdermal Skin Patch Market by Country
      • 9.1.1 Central & South America Transdermal Skin Patch Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Transdermal Skin Patch Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Transdermal Skin Patch Market Status

    • 10.1 Middle East & Africa Transdermal Skin Patch Market by Country
      • 10.1.1 Middle East & Africa Transdermal Skin Patch Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Transdermal Skin Patch Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Transdermal Skin Patch Manufacturing Cost Analysis
    • 11.5 Transdermal Skin Patch Sales Channel and Distributors Analysis
      • 11.5.1 Transdermal Skin Patch Sales Channel
      • 11.5.2 Transdermal Skin Patch Distributors
    • 11.6 Transdermal Skin Patch Downstream Major Buyers

    12 Global Transdermal Skin Patch Market Forecast by Category and by End User/Segment

    • 12.1 Global Transdermal Skin Patch Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Transdermal Skin Patch Forecast by Category
      • 12.2.1 Global Transdermal Skin Patch Sales Volume Forecast by Category
      • 12.2.2 Global Transdermal Skin Patch Sales Value Forecast by Category
      • 12.2.3 Global Transdermal Skin Patch Price Forecast by Category
    • 12.3 Global Transdermal Skin Patch Forecast by End User/Segment
      • 12.3.1 Global Transdermal Skin Patch Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Transdermal Skin Patch Sales Value Forecast by End User/Segment
      • 12.3.3 Global Transdermal Skin Patch Price Forecast by End User/Segment

    13 Global Transdermal Skin Patch Market Forecast by Region/Country

    • 13.1 Global Transdermal Skin Patch Market Forecast by Region (2022-2027)
      • 13.1.1 Global Transdermal Skin Patch Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Transdermal Skin Patch Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Teva Pharmaceutical Industries Ltd.
      • 14.1.1 Company Information
      • 14.1.2 Transdermal Skin Patch Product Introduction
      • 14.1.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Teikoku Pharma
      • 14.2.1 Company Information
      • 14.2.2 Transdermal Skin Patch Product Introduction
      • 14.2.3 Teikoku Pharma Transdermal Skin Patch Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Rfl Pharmaceutical
      • 14.3.1 Company Information
      • 14.3.2 Transdermal Skin Patch Product Introduction
      • 14.3.3 Rfl Pharmaceutical Transdermal Skin Patch Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Purdue Pharma L.P.
      • 14.4.1 Company Information
      • 14.4.2 Transdermal Skin Patch Product Introduction
      • 14.4.3 Purdue Pharma L.P. Transdermal Skin Patch Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Novartis
      • 14.5.1 Company Information
      • 14.5.2 Transdermal Skin Patch Product Introduction
      • 14.5.3 Novartis Transdermal Skin Patch Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Mylan
      • 14.6.1 Company Information
      • 14.6.2 Transdermal Skin Patch Product Introduction
      • 14.6.3 Mylan Transdermal Skin Patch Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Mundipharma
      • 14.7.1 Company Information
      • 14.7.2 Transdermal Skin Patch Product Introduction
      • 14.7.3 Mundipharma Transdermal Skin Patch Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Luye Pharma Group Ltd.
      • 14.8.1 Company Information
      • 14.8.2 Transdermal Skin Patch Product Introduction
      • 14.8.3 Luye Pharma Group Ltd. Transdermal Skin Patch Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Johnson & Johnson
      • 14.9.1 Company Information
      • 14.9.2 Transdermal Skin Patch Product Introduction
      • 14.9.3 Johnson & Johnson Transdermal Skin Patch Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Hisamitsu Pharmaceutical
      • 14.10.1 Company Information
      • 14.10.2 Transdermal Skin Patch Product Introduction
      • 14.10.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Henan Lingrui Pharmaceutical
    • 14.12 Changzhou Siyao
    • 14.13 Actavis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Transdermal Skin Patch market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Transdermal Skin Patch market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Fentanyl Transdermal Skin Patch
      Nicotine Transdermal Skin Patch
      Clonidine Transdermal Skin Patch
      Buprenorphine Transdermal Skin Patch

      Segmented by End User/Segment
      Relieve Severe Pain
      Stop Smoking Cigarettes
      Treat an Overactive Bladder
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Teva Pharmaceutical Industries Ltd.
      Teikoku Pharma
      Rfl Pharmaceutical
      Purdue Pharma L.P.
      Novartis
      Mylan
      Mundipharma
      Luye Pharma Group Ltd.
      Johnson & Johnson
      Hisamitsu Pharmaceutical
      Henan Lingrui Pharmaceutical
      Changzhou Siyao
      Actavis
      Buy now